Tandem Diabetes Care, Inc. (TNDM) Return on equity 2018–2025
Tandem Diabetes Care, Inc. (TNDM) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-131.9%FY2025 · since FY2018: -93.4% → -131.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -131.9% | -95.4 pp |
| FY2024 | -36.5% | +34.5 pp |
| FY2023 | -71.0% | -49.5 pp |
| FY2022 | -21.5% | -25.1 pp |
| FY2021 | 3.6% | +13.0 pp |
| FY2020 | -9.4% | +3.3 pp |
| FY2019 | -12.7% | +80.7 pp |
| FY2018 | -93.4% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More TNDM financial trends
TNDM RevenueTNDM Net incomeTNDM Net marginTNDM Gross profitTNDM Gross marginTNDM Operating incomeTNDM Operating marginTNDM Operating cash flowTNDM Free cash flowTNDM Capital expendituresTNDM Stock buybacksTNDM Dividends paidTNDM Total assetsTNDM Total liabilitiesTNDM Shareholders’ equityTNDM overview →